LP-40 Metabolome analysis reveals a distinct response of renal cell carcinoma and non-tumoral renal cells to sunitinib and pazopanib. (1st September 2022) - Amaro, F.; Pisoeiro, C.; Valente, M.J.; Bastos, M.D.L.; de Pinho, P. Guedes; Carvalho, M.; Pinto, J.